The Honest Company, Inc. (HNST)
NASDAQ: HNST · Real-Time Price · USD
3.370
+0.120 (3.69%)
At close: Jun 8, 2026, 4:00 PM EDT
3.310
-0.060 (-1.78%)
After-hours: Jun 8, 2026, 7:53 PM EDT

The Honest Company Earnings Call Transcripts

Fiscal Year 2026

  • AGM 2026

    The meeting opened with board introductions and proceeded to two proposals: electing three directors and ratifying the auditor. Both proposals passed with a quorum present, and no questions were raised by shareholders during the session.

  • Q1 2026 saw 3.9% organic revenue growth and record adjusted gross margin of 43.5%, led by wipes and personal care. Household penetration reached 8.1%, while diaper declines moderated. Full-year guidance is reaffirmed, with strong cash flow and continued investment in marketing.

Fiscal Year 2025

  • Organic revenue grew 5.3% in 2025, driven by wipes and personal care, while diapers declined due to retailer shifts and consumer trade-down. 2026 guidance calls for 4%-6% organic growth, margin expansion, and continued innovation, supported by a strong balance sheet and a $25M share repurchase program.

  • Q3 revenue fell 7% year-over-year due to Diapers and Apparel declines, but Wipes and Personal Care saw double-digit growth. Transformation 2.0 will exit low-margin businesses, focus on core categories, and drive cost savings, with organic revenue expected to grow 4%-6% in 2025.

  • Delivered record gross margin and second consecutive quarter of positive net income, with revenue of $93 million and strong growth in wipes and personal care segments. Reaffirmed full-year outlook despite tariff and macroeconomic headwinds, supported by new product launches and expanded distribution.

  • Q1 2025 saw 13% revenue growth, gross margin expansion to 39%, and $3M net income, driven by strong wipes and sensitive skin portfolios. Despite diaper headwinds and tariff risks, full-year guidance is reaffirmed, with ongoing investment in brand and margin initiatives.

  • A focused transformation initiative drove double-digit revenue growth, margin expansion, and positive earnings, supported by portfolio optimization and expanded distribution. Significant opportunities remain for hero products and further retail penetration, with a strong market position in clean, modern personal care.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by